Apramycin Resistance in Human Bacteria from a Systematic Review

A dataset of extracted data from a systematic review and meta-analysis on apramycin resistance in bacteria isolated from humans. The data was compiled by author J. Scott Weese and last updated in May 2026. The study aims to inform the potential repurposing of the veterinary aminoglycoside for clinical human use.

Use Cases

• Estimating baseline resistance rates to apramycin based on aggregated study data.
• Identifying knowledge gaps in apramycin susceptibility testing for human pathogens.
• Informing drug development and repurposing decisions for Gram-negative infections.

Strengths

• Data originates from a systematic review and meta-analysis, suggesting a structured collection methodology.
• The dataset is focused on a specific, emerging research question regarding apramycin repurposing.

Limitations

• Row count and column-level documentation are absent, which limits suitability assessment.
• Description metadata is limited; actual data quality requires manual inspection after download.

Provenance

Source

Borealis Harvested Dataverse

Collection Method

Extracted data from a systematic review and meta-analysis.

Freshness

Last updated 2026-05-02 04:10:46; freshness should be verified.